Complete financial analysis of Delic Holdings Corp. (DELCF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Delic Holdings Corp., a leading company in the Internet Content & Information industry within the Communication Services sector.
- Chromatic India Limited (CHROMATIC.NS) Income Statement Analysis – Financial Results
- Kanefusa Corporation (5984.T) Income Statement Analysis – Financial Results
- EVe Mobility Acquisition Corp (EVE-UN) Income Statement Analysis – Financial Results
- IceCure Medical Ltd (ICCM.TA) Income Statement Analysis – Financial Results
- Austerlitz Acquisition Corporation I (AUS-UN) Income Statement Analysis – Financial Results
Delic Holdings Corp. (DELCF)
Industry: Internet Content & Information
Sector: Communication Services
Website: https://deliccorp.com
About Delic Holdings Corp.
Delic Holdings Corp. provides various medicines and treatments in the United States and Canada. It operates The Delic, a creative platform that creates and hosts public discourse about psychedelic culture; Meet Delic, which organizes event to promote topics, such as safety and harm reduction, Hollywood, mental health and psychedelics, the power of integration, human performance, medicine, and other topics; Reality Sandwich, a public online education platform with approximately 10,000 pieces of content, including psychedelic guides, news, and culture; and Delic Radio, a podcast that discusses topics related to the psychedelic space with experts comprising discussions relating to news, science, culture, medicine, current affairs, and policy. The company also focuses on developing intellectual property through research and development for cannabis and psychedelics. In addition, it owns and operates two ketamine infusion treatment clinics; and thirteen ketamine infusion treatment clinics. The company is headquartered in Vancouver, Canada.
| Metric | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|
| Revenue | 1.98M | 0.00 | 4.49M | 0.00 |
| Cost of Revenue | 2.02M | 74.81K | 3.28M | 0.00 |
| Gross Profit | -41.00K | -74.81K | 1.21M | 0.00 |
| Gross Profit Ratio | -2.07% | 0.00% | 26.97% | 0.00% |
| Research & Development | 214.00K | 46.11K | 0.00 | 0.00 |
| General & Administrative | 5.19M | 732.10K | 137.24K | 41.11K |
| Selling & Marketing | 1.94M | 232.62K | 144.29K | 0.00 |
| SG&A | 7.13M | 964.73K | 137.24K | 41.11K |
| Other Expenses | 0.00 | 39.96K | 0.00 | 0.00 |
| Operating Expenses | 1.57M | 1.01M | 137.24K | 41.11K |
| Cost & Expenses | 9.20M | 1.01M | 137.24K | 41.11K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 25.26 | 18.35 |
| Depreciation & Amortization | 131.38K | 16.71K | 13.13K | 161.14K |
| EBITDA | -5.75M | -489.47K | 467.56K | -41.11K |
| EBITDA Ratio | -290.32% | 0.00% | -3.06% | 0.00% |
| Operating Income | -7.22M | -383.85K | -137.24K | -41.11K |
| Operating Income Ratio | -364.62% | 0.00% | -3.06% | 0.00% |
| Total Other Income/Expenses | -2.27M | -423.58K | -377.98K | -18.35 |
| Income Before Tax | -9.49M | -1.60M | -137.26K | -41.13K |
| Income Before Tax Ratio | -479.19% | 0.00% | -3.06% | 0.00% |
| Income Tax Expense | -628.00K | 420.69K | -0.77 | -161.14K |
| Net Income | -8.86M | -1.60M | -137.26K | -41.13K |
| Net Income Ratio | -447.48% | 0.00% | -3.06% | 0.00% |
| EPS | -0.16 | -0.18 | 0.00 | 0.00 |
| EPS Diluted | -0.16 | -0.18 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 54.75M | 9.11M | 37.67M | 38.12M |
| Weighted Avg Shares Out (Dil) | 54.75M | 9.11M | 38.12M | 38.12M |
Delic Labs to Present on Psychedelics, Cannabis Extraction at Grow Up Conference and Expo
Brittany Hoogenboom, Founder of Synergy Soul and Holistic Business Coach, To Headline At Meet Delic: The World's Premiere Psychedelic and Wellness Event
Ketamine Wellness Centers Partners with Veterans Affairs (VA) Community Care Network to Provide Free Ketamine Treatments to Veterans
Duncan Trussell, Actor, Stand-Up Comedian & Host of the Duncan Trussell Family Hour Podcast, To Keynote At Meet Delic: The World's Premiere Psychedelic and Wellness Event
Delic Labs Applies for Dealer's License to Commercialize Psychedelics Research, Health Exemption to Test MDMA and LSD
Dr. Molly Maloof, Physician, Technologist and Entrepreneur, To Keynote At Meet Delic: The World's Premiere Psychedelic and Wellness Event
Delic Holdings Teams Up With Paradigm Healthcare To Bring Toxicology Testing Solution To Ketamine Treatment, Raises $7M To Expand Psychedelic Wellness Clinic
Delic Partnership with Paradigm Healthcare of Georgia Brings Clinically Relevant Toxicology Testing to Ketamine Treatment for First Time
Delic Closes C$7.0 Million Private Placement With U.S. Institutional Investor to Fuel Growth of Largest National Presence
Lamar Odom and His Life-Saving Journey with Psychedelics
Source: https://incomestatements.info
Category: Stock Reports